Maxar Technologies completes acquisition of VA-based Vricon, Inc.
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced it has completed its previously announced acquisition of 3D data and analytics firm Vricon, Inc., for approximately $140 million,... Read More
Thursday July 2, 2020 0 comments
Maxar Technologies announces it will acquire Vricon to accelerate growth in emerging markets for 3D tech
WESTMINSTER -- Maxar Technologies announced its intent to acquire 3D data and analytics firm Vricon, Inc., for approximately $140 million -- or approximately $115 million net of estimated cash at... Read More
Wednesday June 24, 2020 0 comments
Flagship Biosciences names Aymii Couzelis chief information officer
WESTMINSTER -- Flagship Biosciences , providers of expert tissue data insights, today announced Aymii Couzelis has been named to its executive team as chief information officer. Couzelis... Read More
Wednesday May 27, 2020 0 comments
Maxar selected to support Dynetics in designing and building a lunar human landing system for NASA
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced that it has been selected to support Dynetics , a wholly-owned subsidiary of Leidos, in designing and building a Human Landing... Read More
Friday May 1, 2020 0 comments
Maxar selected to deliver services to U.S. NGA
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced it signed $20 million in contracts with the U.S. National Geospatial-Intelligence Agency (NGA) to deliver land cover... Read More
Tuesday April 28, 2020 0 comments
Maxar Technologies selected by NASA to build Intelsat satellite and SPIDER robotic arm
WESTMINSTER -- Virginia-based Intelsat (NYSE: I) has selected Maxar Technologies (NYSE:MAXR) (TSX:MAXR) to manufacture Intelsat 40e, a next-generation geostationary communications satellite... Read More
Monday February 3, 2020 0 comments
Maxar to sell Canadian-based MDA for $765M
WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced it will sell MDA to a consortium of financial sponsors led by Northern Private Capital (NPC) for $765 million. The company... Read More
Monday January 6, 2020 0 comments
Cerapedics announces FDA approval of PMA supplement based on two-year clinical data
WESTMINSTER -- Cerapedics, a private ortho-biologics company, announced the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) supplement for i-FACTOR... Read More
Tuesday November 19, 2019 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
